- SAVA -0.39%
Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright After Key Golden Cross
Yahoo Finance · 1 day ago
Open | 21.57 |
High | 22.80 |
Low | 21.45 |
Mkt Cap | 1.04B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 21.80 |
52 Wk. Low | 12.32 |
52 Wk. High | 32.10 |
Related stocks
American pharmaceutical company
Cassava Sciences is an American pharmaceutical company based in Austin, Texas. The company was founded in 1998 by chief executive officer and president Remi Barbier as Pain Therapeutics, Inc., changing its name in 2019. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | - | - |
Net Income | 25.04M | - |
Diluted EPS | 0.58 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.40 | - |
Q1 2024 | -$0.46 | $0.58 |
Q4 2023 | -$0.52 | -$0.50 |
S&P 500^GSPC | 5,304.72+36.88 (+0.70%) |
Dow 30^DJI | 39,069.59+4.33 (+0.01%) |
Nasdaq^IXIC | 16,920.79+184.76 (+1.10%) |
19.00+3.71% | |
0.9830+428.49% | |
CAVA Group, Inc.CAVA | 82.93+6.87% |